Who
Mitchell Shirvan
CSO and CDO
Company insider
Files Form 4 as: CSO and CDO, Silexion Therapeutics; VP Innovation & Discovery, Foamix Pharmaceuticals.
In numbers
- Trades disclosed
- 12
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $62K
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 1 Jan 2018
- Last trade
- 4 Jun 2026
- Last filed
- 8 Jun 2026
Companies traded
Activity over time
1 Mar – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Jun 2026filed 8 Jun 2026 | SLXN Silexion TherapeuticsBiotechnology | SEC FORM 4 Code A | —6,000 at $0.00 | filing |
| 4 Jun 2026filed 8 Jun 2026 | SLXN Silexion TherapeuticsBiotechnology | SEC FORM 4 Code A | —6,000 at $0.00 | filing |
| 26 Mar 2026filed 30 Mar 2026 | SLXN Silexion TherapeuticsBiotechnology | SEC FORM 4 Sold | $31K22,818 at $1.36 | filing |
| 26 Mar 2026filed 30 Mar 2026 | SLXN Silexion TherapeuticsBiotechnology | SEC FORM 4 Sold | $31K22,818 at $1.36 | filing |
| 20 Feb 2026filed 23 Feb 2026 | SLXN Silexion TherapeuticsBiotechnology | SEC FORM 4 Code A | —49,726 at $0.00 | filing |
| 20 Feb 2026filed 23 Feb 2026 | SLXN Silexion TherapeuticsBiotechnology | SEC FORM 4 Code A | —49,726 at $0.00 | filing |
| 27 Feb 2018filed 28 Feb 2018 | Foamix Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | $96K15,000 at $6.40 | filing |
| 27 Feb 2018filed 28 Feb 2018 | Foamix Pharmaceuticals | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 15 Jan 2018filed 24 Jan 2018 | Foamix Pharmaceuticalsoption or derivative | SEC FORM 4 Code M | —562 at $0.00 | filing |
| 15 Jan 2018filed 24 Jan 2018 | Foamix Pharmaceuticals | SEC FORM 4 Code M | —562 at $0.00 | filing |
| 1 Jan 2018filed 24 Jan 2018 | Foamix Pharmaceuticalsoption or derivative | SEC FORM 4 Code M | —2,745 at $0.00 | filing |
| 1 Jan 2018filed 24 Jan 2018 | Foamix Pharmaceuticals | SEC FORM 4 Code M | —2,745 at $0.00 | filing |
News
Silexion Therapeutics Corp (NASDAQ:SLXN) Shares Shorted: Short Interest Up 1,964.4% in SeptemberSLXN · themarketsdaily.com · 10 Oct 2026
0 headlines in the last 90 days name Mitchell Shirvan; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.